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Abstract 29 
 30 
Ornithodoros erraticus is an argasid tick that can transmit severe diseases such as 31 
human relapsing fever and African swine fever. In the search for a vaccine against this parasite, 32 
a crude extract of tick midgut membranes (GME) was obtained that in pigs and mice induced a 33 
protective response able to kill up to 80% of the nymphs in the first 72 h post-feeding and to 34 
reduce the fecundity of females by more than 50%. To identify the protective antigens, the 35 
GME was subjected to successive biochemical fractionations and the resulting simpler protein 36 
fractions were inoculated in pigs. A 45-kDa antigen, the so-called Oe45, was detected, purified 37 
and demonstrated to be responsible for the protection induced by the GME. Oe45 seems to be a 38 
membrane protein that is presumably expressed on the luminal membrane of midgut epithelial 39 
cells. Oe45 consists of at least two differently charged bands (cationic and neutral), which show 40 
antigenic cross-reactivity. The possibility that these bands might be different isoforms of the 41 
same protein is discussed. Although Oe45 is constitutively expressed at low levels throughout 42 
the trophogonic cycle, its expression is up-regulated by the ingestion of blood, as suggested by 43 
the higher levels observed between 6 and 72 h post-feeding. 44 
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1. Introduction. 53 
 54 
In southern Europe, the argasid tick Ornithodoros erraticus lives in close association 55 
with swine on free-range pig farms, hidden in holes and fissures inside and around pig-pens 56 
(Oleaga-Pérez et al., 1990). The O. erraticus life cycle comprises the phases of egg, larva, up to 57 
five consecutive nymphal stages (nymph-1 to nymph-5) and adult. Except for the egg, all these 58 
developmental stages are haematophagous, requiring a blood meal to moult (immature forms) 59 
and reproduce (adults). O. erraticus is of veterinary importance because it is a well-established 60 
vector for the African swine fever virus (Sánchez Botija, 1963, 1982; Wilkinson, 1984), which 61 
causes a highly contagious disease in domestic swine with a broad range of clinical forms, 62 
varying from hyperacute to chronic or unapparent (Basto et al., 2006). In addition, O. erraticus 63 
is important from a medical point of view since it transmits several species of tick-borne 64 
relapsing fever borreliae, such as Borrelia hispanica and B. crocidurae (Piesman and Gage, 65 
2004) to humans. Accordingly, control of O. erraticus would greatly improve the control of 66 
these diseases. 67 
Current tick control is based on the use of acaricides, but these chemicals have serious 68 
drawbacks, including the development of resistance in ticks, toxicity, contamination of food 69 
products and environmental pollution (Graf et al., 2004). Moreover, in the case of O. erraticus, 70 
acaricide use has proved to be inefficient for the elimination of this tick from pig farms simply 71 
because it is not feasible to ensure that the acaricide will reach all the places where the parasite 72 
hides (Astigarraga et al., 1995). 73 
This is why our team started to develop an anti-O. erraticus vaccine as an alternative 74 
method of control. In the search for suitable antigenic targets, which is the primary rate-limiting 75 
step in further vaccine development (Willadsen, 2004; Nuttall et al., 2006), we tested exposed -76 
or salivary- antigens as well as several extracts of concealed antigens from the tick gut, 77 
haemolymph, synganglion and coxal glands (Astigarraga et al., 1995; Manzano-Román et al., 78 
2006). Although some degree of protection -reflected as up to 50% inhibition of tick feeding- 79 
was achieved with salivary antigens (Astigarraga et al., loc. cit.), the highest degree of 80 
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protection was provided by an antigenic extract made of the midgut membranes of the tick, the 81 
so-called GME (Manzano-Román et al., loc. cit.).  82 
Administration of the GME with Freund’s adjuvants (FAs) to pigs and mice induced a 83 
protective response that killed up to 80% of the immature forms of the parasite in the first 72 84 
hours post-feeding and reduced the fecundity of the females by more than 50%. The action of 85 
the vaccine was the result of damage to the midgut wall of the argasid, and, at least in mice, this 86 
damage is mediated by activation of the complement system. The protective antigens of the 87 
GME are expressed by all the developmental stages of O. erraticus and are probably membrane 88 
proteins of the luminal surface of midgut epithelial cells. These antigens are more abundant in 89 
recently fed parasites than in fasting ticks, suggesting that their expression is induced after 90 
blood ingestion (Manzano-Román et al., 2006). 91 
The aim of the present work was to purify, characterize and identify the protective 92 
antigen(s) from the GME. This was accomplished following the pragmatic approach referred to 93 
by Willadsen (2004). That is, the GME was subjected to successive biochemical fractionations 94 
and the resulting simpler protein fractions were inoculated to the swine. In this way, a 45-kDa 95 
protective antigen was detected, purified and partly characterized. 96 
 97 
2. Material and Methods. 98 
 99 
2.1. Animals. 100 
 101 
A total of 39 pigs were used as hosts in the vaccination experiments. All pigs were 102 
Iberian breed females with an initial weight of 15 kg. They were from a farm free of 103 
ectoparasites. Along the experimental period they were fed on non-medicated commercial feed. 104 
 105 
2.2. Parasites 106 
 107 
 5 
In all experiments we used specimens of O. erraticus from a pathogen-free laboratory 108 
colony established from ticks captured in Salamanca, western Spain. The ticks were fed 109 
regularly on rabbits and were kept in an environmental chamber at 28 ºC, 85 % relative 110 
humidity and 16 h light / 8 h darkness. These ticks were used as the source of antigenic material 111 
and to test the action of the immune response induced by vaccination. 112 
 113 
2.3. Preparation of midgut membrane extracts of O. erraticus 114 
 115 
Extracts were routinely obtained from fed adult ticks taken at 72 hours post-feeding 116 
(p.f.). For one particular experiment, however, additional extracts were also prepared from 117 
fasting adults and from fed adults taken at 6 and 48 hours, and 15 and 23 days p.f. As a general 118 
rule, the specimens were processed in batches of 50 individuals per batch (25 males and 25 119 
females). 120 
A detailed description of the procedure for the preparation of the midgut membrane 121 
extracts can be found in Manzano-Román et al. (2006). Essentially, the procedure consisted in 122 
dissecting, emptying and washing the midgut, followed by osmotic lysis of the epithelial midgut 123 
cells in order to remove their cytoplasmic contents, and finally fragmentation of the cell 124 
membranes and basal membrane by sonication. The resulting suspension was the so-called 125 
midgut membrane extract (GME) and its protein concentration was estimated by the method of 126 
Markwell et al. (1978). 127 
 128 
2.4. Fractionation of GME components. 129 
 130 
GME components were first separated into three fractions according to their solubility. 131 
The GME was centrifuged for 1 h at 100,000 g and 4 ºC. The supernatant (containing water 132 
soluble proteins) was recovered, and the pellet was re-suspended in phosphate buffered saline 133 
(PBS) and centrifuged as before. The supernatant was then discarded and the new pellet was re-134 
suspended in fresh PBS containing 1% Triton X-100 (TX-100) and allowed to incubate for 1 h 135 
 6 
at 4 ºC with gentle shaking. After a new centrifugation step at 100,000 g, the resulting 136 
supernatant (enriched in TX-100-soluble membrane proteins from midgut epithelial cells) was 137 
recovered. The pellet was washed with PBS containing 1% TX-100, re-centrifuged and, finally, 138 
resuspended in fresh PBS. This final suspension contained the TX-100 insoluble proteins, which 139 
are most likely proteins of the basal membrane of the midgut wall (Balashov, 1972). The protein 140 
concentration of these three fractions was measured by the method of Markwell et al. (1978). 141 
The TX-100-soluble membrane proteins were subsequently fractionated according to 142 
their electrical charge. This was carried out using the Sep-Pak disposable ion-exchange 143 
cartridges Accell™ Plus QMA -anion exchanger- and Accell™ Plus CM -cation exchanger- 144 
from Waters (Milford, Massachusetts) following the manufacturer’s instructions. First, the 145 
sample containing the membrane proteins (nearly 3 mg in 4 ml) was concentrated to 0.3 ml 146 
through 3K Microsep filters (Filtron, Northborough, Massachusetts) and then diluted with 50 147 
mM ammonium acetate buffer, pH 5.5, to a final volume of 3 ml. Then, both cartridges were 148 
connected in tandem and washed with 20 ml of ammonium acetate buffer, pH 5.5, at a flow rate 149 
of 2 ml/min. The protein sample was then applied on the upper cartridge at 0.5-1 ml/min and 150 
unbound (neutral) proteins were immediately eluted with 6 ml (0.5-1 ml/min) of ammonium 151 
acetate buffer, pH 5.5. Following this, the cartridges were disconnected and each of them was 152 
eluted with 5 ml (0.5-1 ml/min) of ammonium acetate buffer, pH 5.5, containing 1M NaCl to 153 
extract the anionic and the cationic proteins respectively. The three eluates were then 154 
concentrated through 3K Microsep filters and their final protein concentration was measured by 155 
the method of Markwell et al. (1978). 156 
After each round of fractionation, each fraction was analysed by SDS-PAGE and its 157 
protective value was tested in pig vaccination trials. 158 
 159 
2.5. Purification of the Oe45 antigen from the membrane protein fraction of the GME by gel 160 
electroelution. 161 
 162 
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As shown in the Results section, a potential protective antigen of 45 kDa was detected 163 
in the fraction of membrane proteins from the GME. This antigen, designated Oe45, was 164 
purified as follows. The membrane protein fraction of the GME was extracted with 1% TX-100 165 
and resolved by SDS-PAGE. These gels were then stained with copper chloride (Harlow and 166 
Lane, 1988) to visualize the protein bands and cut those of 45 kDa. The gel pieces were 167 
destained and the protein electroeluted from the gel pieces in a model 4222 eluter from Bio-Rad 168 
(Hercules, CA) following the manufacturer’s instructions. The eluted antigen was concentrated 169 
through 3K Microsep filters and its concentration assessed by the method of Markwell et al. 170 
(1978). Following this, its protective value was tested in a pig vaccination trial. 171 
 172 
2.6. Vaccination procedure and collection of sera. 173 
 174 
Unless otherwise indicated, the vaccination protocol was as follows. All pigs were 175 
vaccinated at 15-day intervals with three doses of the corresponding antigen (GME and its 176 
fractions and sub-fractions) administered subcutaneously at four points on their abdomens. Each 177 
dose contained between 150 and 5 µg of protein (Table 1) in 1 ml of PBS. The first dose was 178 
administered emulsified in an equivalent volume of Freund’s complete adjuvant (FCA), the 179 
second with Freund’s incomplete adjuvant (FIA) and the third dose with no adjuvant. The pigs 180 
were bled immediately before the administration of each dose and immediately after each 181 
infestation with parasites. Blood samples were allowed to clot and sera were removed and 182 
stored at -80ºC. 183 
 184 
2.7. Vaccination trials and parasite infestations (Table 1). 185 
 186 
Trial 1. The aim of this was to test which of the GME fractions obtained by differential 187 
solubilisation contained the protective antigens. Fifteen pigs were divided into five groups of 3 188 
pigs each and treated as follows: Group 1, GME; Group 2, water-soluble proteins; Group 3, 189 
membrane proteins; Group 4, insoluble proteins; control group, adjuvant. Parasite infestations: 190 
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two infestations with 15 females, 25 males and 100 nymphs-2 per pig were carried out at 7 and 191 
14 days after the third antigen dose. 192 
Trial 2. The aim of this was to test which sub-fraction of the GME membrane proteins 193 
contained protective antigens. Fifteen pigs were divided into five groups of 3 pigs each and 194 
treated as follows: Group 1, GME membrane proteins; Group 2, cationic membrane proteins; 195 
Group 3, anionic membrane proteins; Group 4, neutral membrane proteins; control group, 196 
adjuvant. Parasite infestations: two infestations with 15 females, 25 males and 100 nymphs-2 197 
per pig were carried out at 7 and 14 days after the third antigen dose. 198 
Trial 3. The aim of this trial was to assess whether the eluted Oe45 antigen induces a 199 
protective response analogous to that induced by the whole fraction of membrane proteins of the 200 
GME. Nine pigs were divided into three groups of 3 pigs each: Group 1, GME membrane 201 
proteins; Group 2, Oe45 antigen; control group, adjuvant. Parasite infestations: two infestations 202 
with 15 females, 25 males, 100 nymphs-2 and 100 nymphs-1 per pig were carried out on days 7 203 
and 14 after the third antigen dose. 204 
 205 
2.8. Evaluation of the protection induced by the different antigenic extracts and statistics. 206 
 207 
The degree of protection was determined by measuring the usual parameters in ticks fed 208 
on vaccinated animals and comparing the results with those from ticks fed on control animals 209 
(Manzano-Román et al., 2006). These parameters were feeding time, the amount of blood 210 
ingested, the number of eggs laid by the females, egg viability, the moult rate of immature 211 
stages and mortality rates at 48-72 hours, 15 days and 3 months post-feeding. 212 
The values obtained for the parasites fed on the animals from each group were 213 
summarized as means ± standard errors. Statistical differences between the vaccinated groups 214 
and the corresponding controls in each trial were assessed by one-way ANOVA. Values of P < 215 
0.05 were taken to be significant. 216 
 217 
2.9. Humoral response. 218 
 9 
 219 
The levels of IgG antibodies against the GME and its fractions and sub-fractions were 220 
monitored by indirect ELISA according to the standard protocol described previously 221 
(Manzano-Román et al., 2006). Briefly, polystyrene plates (Sigma) were coated with 1 µg of 222 
antigen per well in 100 µl of carbonate buffer, pH 9.6, and post-coated with 1% bovine serum 223 
albumin in PBS. The sera were analysed in duplicate at a dilution of 1/100 in TPBS (PBS 224 
containing 0.05% Tween 20). Peroxidase-conjugated anti-pig IgG (Sigma) was used, diluted 225 
1/6000 in TPBS. Ortho-phenylene-diamine was used as chromogen substrate for peroxidase and 226 
the reactions were stopped with 3N sulphuric acid. 227 
 228 
2.10. SDS-PAGE and Western blots. 229 
 230 
SDS-PAGE and Western blotting were carried out essentially as described elsewhere 231 
(Baranda et al., 2000). The GME and its successive fractions were subjected to SDS-PAGE in a 232 
Laemmli (1970) discontinuous gel system using the Mini-Protean Cell system (Bio-Rad). The 233 
stacking gel was 3% and the resolving gel was a 5-20% gradient. Typically, the gels were 234 
loaded with 10 µg of protein per lane or each 5 mm of gel width. After running, the gels were 235 
either electrotransferred onto nitrocellulose membranes or stained with silver nitrate and 236 
Coomassie blue and dried. The electrotransfer step was carried out over 90 min at 400 mA in 2 237 
mM Tris, 192 mM glycine buffer, pH 8. The sheets were cut into 5 mm strips, post-coated with 238 
1.5% BSA in PBS and then incubated with different sera diluted 1/100. After washing, the strips 239 
were incubated with 1/2000-diluted peroxidase-conjugated anti-pig-IgG. Finally, the reactive 240 
bands were developed using 4-chloro-1-naphthol as chromogen. The dried gels and the 241 
nitrocellulose strips were scanned directly and processed digitally to compose the corresponding 242 
figures. 243 
 244 
3. Results 245 
 246 
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3.1. Vaccination of pigs with GME and GME fractions obtained by differential solubilisation: 247 
humoral response, antigens recognized by the vaccinated animals, and effect of the response in 248 
O. erraticus. 249 
 250 
Fig. 1(A) shows that the three GME fractions induced medium to high anti-GME IgG 251 
serum levels in the pigs and that the whole GME induced an antibody response that was even 252 
higher than those induced by its fractions. 253 
Almost 9% of the proteins of the GME were water-soluble; up to 60% were membrane 254 
proteins soluble in TX-100, while the remaining 31% were proteins insoluble in TX-100. 255 
Consequently, the whole GME and the membrane protein fraction showed quite similar band 256 
patterns in SDS-PAGE, whereas the fractions containing the water-soluble and TX-100-257 
insoluble proteins showed band patterns that differed significantly (Fig. 1(B)). These similarities 258 
and differences were even more patent in the Western blots (Fig. 1(C)), where the pigs 259 
vaccinated with the whole GME and with the membrane proteins recognized almost the same 260 
antigens; namely, those of 100, 97, 73, 68, 45, 43 and 12-8 kDa, while the pigs vaccinated with 261 
the water-soluble and the TX-100-insoluble proteins showed completely different antigenic 262 
patterns, consisting in a few bands between 250 and 68 kDa. 263 
The protective action of the response was assessed in 2 infestations with 25 males, 15 264 
females and 100 nymphs-2 per pig and per infestation (Table 2). The GME fractions containing 265 
the water-soluble and the TX-100-insoluble proteins induced responses that were innocuous for 266 
the parasite since no differences were observed in any of the parameters measured between 267 
these two groups and the control group in any of the infestations. By contrast, the whole GME 268 
and the fraction containing its membrane proteins induced very similar protective responses 269 
which, although they did not affect the feeding time, the amount of blood ingested by the 270 
different developmental stages or the mortality of adults (data not shown) did elicit a nearly 271 
50% reduction in the fecundity of females, together with the death of 58.1-71.9% of nymphs-2 272 
in the first 72 h post-feeding (Table 2). The nymphs that did not die in the first 72 h survived 273 
with no apparent damage and moulted normally. 274 
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 275 
3.2. Vaccination of pigs with the fraction of membrane proteins and its sub-fractions containing 276 
membrane proteins of different charge: humoral response, antigens recognized by the 277 
vaccinated animals, and effect of the response in O. erraticus. 278 
 279 
Fig. 2(A) shows that all the antigenic extracts except the fraction of anionic proteins 280 
induced similar, medium-to-high, IgG serum levels, which peaked after the third antigenic dose. 281 
Anionic proteins, however, induced a noticeably weaker humoral response. 282 
As can be observed in Fig. 2(B), among the membrane proteins the most numerous were 283 
cationic, followed by neutral and anionic proteins. In terms of protein mass, the proportions of 284 
cationic, neutral and anionic proteins were 80%, 18% and 2%, respectively. 285 
Regarding the antigens recognized by the pigs, Fig. 2(C) shows that: (i), pigs vaccinated 286 
with the whole fraction of membrane proteins (positive control group) recognized the same 287 
antigens as the pigs vaccinated with the same extract in trial 1; namely, antigens of 100, 97, 73, 288 
68, 45, 43 and 12-8 kDa; (ii), pigs inoculated with anionic proteins did not reveal any band; (iii), 289 
all the pigs inoculated with cationic proteins revealed a unique band of 45 kDa, and (iv), two of 290 
the three pigs vaccinated with the neutral proteins recognized five antigens of 100, 97, 73, 68 291 
and 45 kDa, while the third pig recognized only the bands of 68 and 45 kDa, and did this so 292 
weakly that those bands were hardly perceptible. In addition, Fig. 2(D) shows the results of a 293 
crossed Western blot in which the pigs vaccinated with the cationic proteins recognised only the 294 
antigen of 45 kDa on the neutral fraction, while pigs vaccinated with neutral proteins recognised 295 
only the antigen of 45 kDa on the cationic fraction. 296 
The action of these responses was assessed in two infestations with 25 males, 15 297 
females, and 100 nymphs-2 per pig and per infestation (Table 3). As in the previous experiment, 298 
the whole fraction of membrane proteins induced a protective response that reduced the 299 
fecundity of females by more than 50%, and killed up to 68% of nymphs-2. Regarding the sub-300 
fractions, the anionic proteins did not induce any protection whereas the cationic and the neutral 301 
proteins induced both the same protective effect and with almost the same intensity; that is, a 302 
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drop in the fecundity of the females between 30% and 62%, and the death of up to 25% of 303 
immature forms (Table 3). The remaining parameters measured showed values similar to the 304 
controls in all groups and infestations (data not shown). 305 
 306 
3.3. Vaccination of pigs with the Oe45 antigen purified by electroelution and with the whole 307 
fraction of membrane proteins: humoral response, antigens recognized by the vaccinated 308 
animals, and effect of the response in O. erraticus. 309 
 310 
As can be observed in Fig. 3(A), the Oe45 antigen administered alone induced a 311 
humoral response almost as high as that induced by the whole membrane protein fraction, from 312 
which it was purified and where it accounted for the 4% of the protein mass (Fig. 3(B)). Pigs 313 
vaccinated with Oe45 recognized only this antigen on the whole GME (Fig. 3(C)) whereas pigs 314 
vaccinated with the whole fraction of membrane proteins recognized a similar antigenic pattern 315 
to that shown by pigs vaccinated with this same extract in trials 1 and 2. 316 
The protective actions of the responses induced in this trial were assessed in two 317 
infestations with 25 males, 15 females, 100 nymphs-2 and 100 nymphs-1 per pig and per 318 
infestation (Table 4). As in trials 1 and 2, the response against the membrane protein fraction 319 
reduced the fecundity of females by nearly 50% and killed between 65.1% and 78% of the 320 
nymphs. The Oe45 antigen also induced the same protective effects but with less intensity, that 321 
is, a 35%-42% reduction in the fecundity of females and the death of about 25% of the nymphs. 322 
 323 
3.4. Expression of the Oe45 antigen along the trophogonic cycle. 324 
 325 
 The sera of the pigs vaccinated with Oe45 in trial 3 were used as a specific probe to 326 
assess the presence of Oe45 in the GMEs obtained from fasted adults and from fed adults taken 327 
at different times along the period of blood digestion. Fig. 4 shows that the Oe45 antigen was 328 
present in the GME from fasted specimens as well as in the GME from specimens taken at any 329 
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time of their trophogonic cycle. However, Oe45 was clearly more abundant in the GME from 330 
specimens taken between 6 and 72 h p.f., and particularly between 48 and 72 h p.f. 331 
 332 
4. Discussion 333 
  334 
As indicated in the Introduction section, our aim in this work was to isolate, 335 
characterize and identify the protective antigen(s) from the crude extract of midgut membranes 336 
(GME) of O. erraticus. Since the GME obtained from adult ticks taken at 72 h p.f. (GME72h) 337 
was richer in protective antigens than the GME from fasted adults and even from adults taken at 338 
6 h p.f. (Manzano-Román et al., 2006) we used GME72h as the starting material for the 339 
isolation and purification of the antigens. GME72h is an extract with a complex composition in 340 
which the sera from protected animals recognise many antigens, such that any of them could, in 341 
principle, be responsible for the protection. With a view to progressively pinpointing the range 342 
of potential protective antigens, the GME72h was subjected to successive biochemical 343 
fractionations and the resulting simpler protein fractions were inoculated in pigs. 344 
In the first fractionation, carried out as a function of the solubility of the GME72h 345 
components, we observed that although GME72h is a membrane extract theoretically free of 346 
water-soluble remains, it still had 9% of water-soluble proteins (Fig. 2(B)). Although according 347 
to Astigarraga et al. (1995) these water-soluble proteins have no protective value, they were, 348 
however, administered to a batch of pigs before being fully discarded (trial 1). As expected, the 349 
response induced by this fraction was not protective at all (Table 2). Neither was protective the 350 
response induced by the fraction containing TX-100-insoluble components. This lack of 351 
protection was not surprising since this fraction would contain essentially insoluble proteins 352 
from the basal membrane lying beneath midgut epithelial cells (Balashov, 1972), such that these 353 
proteins are not directly exposed to the host’s immune effectors (antibodies and complement) 354 
ingested with blood. Unlike the previous fractions, the one formed by the components 355 
solubilised with TX-100 induced a protective response similar to that of the complete GME 356 
(Table 2), indicating that it was indeed this fraction that contained the protective antigens. Since 357 
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this fraction is basically formed by TX-100-soluble membrane proteins (Van Renswoude and 358 
Kempf, 1984; Hjelmeland, 1990) it is reasonable to surmise that the protective antigens would 359 
be membrane proteins and that they would be expressed on the luminal membrane of midgut 360 
epithelial cells, where they can be readily targeted by the host antibodies and complement 361 
ingested with blood. Nevertheless, this presumed luminal expression of the protective antigens 362 
must be demonstrated directly (i.e., by immunolocalization) before any firm conclusions can be 363 
drawn. 364 
Since the membrane fraction continued to be somewhat complex and still displayed 365 
many antigens recognised by the protected animals (Fig. 1(B), 1(C)), it was subjected to further 366 
fractionation, in this case as a function of the electrical charge of its components, after which we 367 
examined the protective value of the new fractions. The results of this experiment (trial 2) 368 
revealed, on one hand, that the anionic proteins induced weak responses, lacking protective 369 
value, and -on the other- that there were protective antigens in both the cationic and neutral 370 
protein fractions (Fig. 2 and Table 3).  371 
At first sight, the weak response induced by the anionic fraction could be attributed to 372 
the lower amount of anionic protein administered per dose (10 µg) as compared to the doses of 373 
cationic (100 µg) and neutral fractions (50 µg). However we surmise that this was not the cause 374 
owing to the following reasons: first, because the anionic fraction contained only two bands 375 
(Fig. 2(B)), which suggests that we would have administered close to 5 µg of each anionic band 376 
per dose, and, second, because such a dose would be sufficiently high to induce a strong 377 
humoral response, as was actually the case of the purified 45 kDa band (see below). Instead, the 378 
weak and non-protective anti-anionic response could be attributed to a low immunogenicity of 379 
the anionic proteins. Evidently, demonstration of this would have required new immunizations 380 
and immunoassays with equivalent amounts of antigen fraction preparations. These assays were 381 
precluded by the very tedious, time-consuming and low-throughput procedure for the 382 
preparation of the fractions. Consequently we focused our attention on the two fractions that 383 
induced a protective immune response: namely, the cationic and neutral proteins. 384 
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Interestingly, trial 2 showed that although the fraction of cationic proteins was the most 385 
complex (Fig. 2(B)), only one of its components -that of 45 kDa- was recognized by the animals 386 
vaccinated -and protected- with this fraction (Fig. 2(C)). This result strongly suggested that this 387 
antigen of 45 kDa, then designated Oe45, could be responsible for the protection induced by this 388 
fraction. 389 
In contrast, the pigs vaccinated with the neutral proteins recognised at least five 390 
antigens in the homologous fraction. Since one of these antigens had a molecular weight of 45 391 
kDa, it was possible that that antigen could be an isoform of the cationic Oe45 or, at least, a 392 
cross-reactive protein of equal weight. To check this, we performed a crossed Western blot, 393 
which revealed that the only antigen recognised in both crossed combinations was the 45 kDa 394 
band, thus confirming that the two 45 kDa proteins shared epitopes (Fig. 2(D)). This finding 395 
supported the notion that both bands might be isoforms of the same protein (although 396 
confirmation of this point requires further studies) and, therefore, that the neutral Oe45 could be 397 
responsible for the protection induced by the fraction of neutral proteins. Were this indeed the 398 
case, it would also account for the lower degree of protection induced by the cationic and 399 
neutral protein fractions (around 25% of nymph mortality) as compared to the protection 400 
induced by the whole membrane protein fraction (up to 68% of nymph deaths) (Table 3), since 401 
with each fraction a smaller dose of protective molecules would have been administered than 402 
with the complete fraction of membrane proteins (see Table 1). 403 
Definitive confirmation that Oe45 was indeed the protective antigen came from trial 3, 404 
after vaccinating a new batch of pigs with 5 µg/dose of Oe45 purified by electroelution and 405 
observing that it induced a protective response that was similar, although less potent, to that 406 
induced by 150 µg/dose of the complete fraction of membrane proteins (Table 4). Since Oe45 407 
represents 4% of the protein mass of the whole membrane protein fraction, the pigs vaccinated 408 
with 150 µg/dose received the equivalent of about 6 µg of Oe45, very close to the dose of 409 
purified Oe45. Accordingly, we believe that the lower degree of protection obtained with the 410 
purified antigen was not due to a difference in the dose but to the probable loss of epitopes 411 
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caused by the denaturing of the proteins during their purification by electroelution from 412 
polyacrylamide gels. 413 
Once the protective antigen had been unveiled, we checked whether, according to the 414 
hypothesis pointed out in the Introduction, its expression was induced by the ingestion of blood 415 
by the parasites. In this sense, the results shown in Fig. 4 seem to confirm such a hypothesis 416 
since although Oe45 was constitutively expressed at low levels throughout the trophogonic 417 
cycle, its expression level increased notably between 6 and 72 h after blood ingestion. This 418 
observation confirmed that, as anticipated by us, GME72h is richer in protective antigens than 419 
the GME from fasting specimens or those taken at 6 h p.f. and, additionally, it would explain 420 
why the parasites fed on the vaccinated swine died between 48 and 72 h p.f., since it was during 421 
that period when they exposed a greater number of target molecules on their midgut, thereby 422 
enhancing the damage derived from the binding of the host antibodies and complement to the 423 
gut wall (see Manzano-Román et al., 2006). Since no data on Oe45 expression levels were 424 
collected between 72 h p.f., when the highest Oe45 level was observed, and 15 days, when 425 
Oe45 again showed basal expression levels, we simply do not know how Oe45 expression 426 
levels change along this time period. However, having in mind that the nymphs that did not die 427 
in the first 72 h p.f. survived with no apparent damage and moulted normally, it would be 428 
reasonable to think that after 72 h p.f. the Oe45 expression levels would decrease rapidly.  429 
Finally, although we attempted the molecular identification of the purified Oe45 by 430 
MALDI-TOF mass spectrometry and Edman N-terminal sequencing we failed to obtain any 431 
result. This outcome was most probably due to insufficient protein purity. Consequently, 432 
forthcoming research will address the molecular identification and cloning of Oe45 in order to 433 
obtain it as a recombinant protein and assess its protective value in combination with adjuvants 434 
permitted for use in animal vaccines instead of Freund’s adjuvants.  435 
 436 
5. Conclusions 437 
 438 
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 The antigen responsible for the protective response induced by GME from O. erraticus 439 
seems to be a membrane protein presumably expressed on the luminal membrane of midgut 440 
epithelial cells. This protein, designated Oe45, has a molecular weight of 45 kDa and splits into 441 
two differently charged bands -cationic and neutral- both of them able to induce protective 442 
responses. Although the Oe45 protein is constitutively expressed at low levels throughout the 443 
trophogonic cycle, its expression is up-regulated by the ingestion of blood, as suggested by the 444 
higher levels observed between 6 and 72 h post-feeding. The molecular identification and 445 
cloning of the Oe45 will be addressed in future work. 446 
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Table 1. 499 
Vaccination trials 500 
 501 
Trial No. Group Antigen Dose (µg) Adjuvantb first-second-third Infestation with 
1 Control 
1 
2 
3 
4 
None 
GMEa 
Water-soluble proteins 
Membrane proteins 
Insoluble proteins 
 
    - 
150 
  50 
150 
150 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
25 males 
15 females 
100 nymph-2 
2 Control 
1 
2 
3 
4 
None 
Membrane proteins 
Cationic membrane proteins 
Anionic membrane proteins 
Neutral membrane proteins 
 
    - 
150 
100 
  10 
  50 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
25 males 
15 females 
100 nymph-2 
3 Control 
1 
2 
None 
Membrane proteins 
Oe45 
 
    - 
150 
    5 
FCA-FIA-PBS 
FCA-FIA-PBS 
FCA-FIA-PBS 
25 males 
15 females 
100 nymph-2 
100 nymph-1 
 502 
a GME, gut membrane extract. 503 
b Adjuvants administered in the first, second and third antigen doses; FCA and IFA, complete and 504 
incomplete Freund’s adjuvant; PBS, phosphate buffered saline. 505 
 506 
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Table 2. 507 
Trial 1. Mean ± SE of the parameters measured in Ornithodoros erraticus specimens fed on control p igs 508 
and on pigs vaccinated with GME and its fractions obtained by differential solub ilisation along the two 509 
infestations. 510 
 511 
Parameter Developmental stage Group/Antigenic extract Infestation 
   First Second 
No. eggs laid Females Control 
GME 
Water-soluble proteins 
Membrane proteins 
Insoluble proteins 
 
89.9 ± 7.3 
56.2 ± 6.7* 
73.9 ± 5.8 
51.0 ± 6.9* 
79.8 ± 9.1 
76.6 ± 5.8 
48.5 ± 4.5* 
70.9 ± 8.2 
41.1 ± 10.4* 
69.9 ± 8.7 
% Viability Eggs Control 
GME 
Water-soluble proteins 
Membrane proteins 
Insoluble proteins  
99.3 ± 9.8 
53.8 ± 5.4* 
95.3 ± 12.3 
35 ± 17.5* 
58.3 ± 25.5* 
58.4 ± 6.2 
15.1 ± 13.5* 
49.4 ± 29.1 
19.3 ± 12.8* 
23.9 ± 18.8 
 
% Mortality 
(72 hours p.f.) 
Nymphs-2 Control 
GME 
Water-soluble proteins 
Membrane proteins 
Insoluble proteins 
7 ± 2.4 
71.8 ± 15.3* 
5.3 ± 1.4 
66.6 ± 19* 
8.6 ± 4.3 
5.1 ± 1.1 
74.3 ± 17.2* 
3 ± 2.1 
60.1 ± 21.3* 
13.6 ± 8.4 
* P < 0.05 with respect to the control group 512 
 22 
 513 
Table 3. 514 
Trial 2. Mean ± SE of the parameters measured in Ornithodoros erraticus specimens fed on control p igs 515 
and on pigs vaccinated with the fraction of membrane proteins and the sub-fractions containing 516 
membrane proteins of different charge along the two infestations. 517 
 518 
Parameter Developmental stage Group/Antigenic extract Infestation 
   First Second 
No. eggs laid Females Control 
Membrane proteins 
Cationic  
Anionic  
Neutral  
 
35 ± 5.5 
14.1 ± 8.8* 
13.3 ± 3.2* 
26.5 ± 6.8 
19.1 ± 14.3 
27.3 ± 3.2 
12.9 ± 7.3* 
17 ± 3.2* 
30.1 ± 2.3 
13.3 ± 12.8 
% Viability Eggs Control 
Membrane proteins 
Cationic  
Anionic  
Neutral 
 
82.3 ± 6.1 
83.6 ± 8.3 
66.9 ± 12* 
74.9 ± 7.8 
70.8 ± 21.2 
36.5 ± 3 
0 ± 0* 
17.6 ± 4.6* 
19.4 ± 7.2 
22,9 ± 15.3 
% Mortality 
(72 hours p.f.) 
Nymphs-2 Control 
Membrane proteins 
Cationic  
Anionic  
Neutral 
0.7± 0.6 
68 ± 8.9* 
25.6 ± 22* 
1.6 ± 0.6 
18.6 ± 13.4* 
1 ± 1 
65.7 ± 6.4* 
19.5 ± 2.8* 
1 ± 1 
25.5 ± 14.3* 
* P < 0.05 with respect to the control group 519 
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 520 
Table 4. 521 
Trial 3. Mean ± SE of the parameters measured in Ornithodoros erraticus specimens fed on control p igs 522 
and on pigs vaccinated with GME and the electroeluted Oe45 antigen along the two infestations 523 
 524 
Parameter Developmental stage Group/Antigen Infestation 
   First Second 
No. eggs laid Females Control 
Membrane proteins 
Oe45  
 
29.8 ± 11.2 
17.7 ± 6.3 
18.3 ± 3.2 
21.1 ± 4 
9.9 ± 9.1 
12 ± 3.7 
% Viability Eggs Control 
Membrane proteins 
Oe45 
 
82.1 ± 6.1 
81.9 ± 18.8 
86.9 ± 12 
28.9 ± 1.9 
0 ± 0* 
18.5 ± 15.6 
Nymphs-2 Control 
Membrane proteins 
Oe45 
 
0.9± 0.5 
78 ± 10.9* 
21.4 ± 23* 
0 ± 0 
65.1 ± 7.8* 
26.8 ± 2.8* 
% Mortality 
(72 hours p.f.) 
Nymphs1 Control 
Membrane proteins 
Oe45 
 
1.6 ± 1.6 
71 ± 5.9* 
25.4 ± 0.9* 
3.1 ± 3.1 
69.2 ± 12.5* 
22.9 ± 1.4* 
* P < 0.05 with respect to the control group 525 
 526 
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 527 
Figure captions 528 
 529 
Figure 1. Vaccination of pigs with GME (gut membrane extract) and GME fractions obtained 530 
by differential solubilisation: water-soluble proteins (Sol.); TX-100-soluble membrane proteins 531 
(Memb.); insoluble proteins in 1% TX-100 (Insol.). (A) Anti-GME IgG serum levels (mean OD 532 
± SE) in control and vaccinated pigs. Asterisks indicate the weeks when the antigenic extract 533 
was administered. The infestations with O. erraticus took place during weeks 5 and 6. (B) SDS-534 
PAGE: band patterns of the GME and the GME fractions. (C) Western blot: antigens recognised 535 
on GME and GME fractions by the sera of pigs vaccinated with the homologous extract. 536 
 537 
Figure 2. Vaccination of pigs with the fraction of membrane proteins (Memb.) and the sub-538 
fractions containing differently charged membrane proteins: cationic (+), anionic (-) and neutral 539 
(Neu). (A) Anti-membrane protein IgG serum levels (mean OD ± SE) in control and vaccinated 540 
pigs. Asterisks indicate the weeks when the antigenic extract was administered. Infestations 541 
with O. erraticus took place during weeks 5 and 6. (B) SDS-PAGE: band patterns of the 542 
membrane proteins and its sub-fractions. (C) Western blot: antigens recognised on the 543 
homologous extract by sera of pigs vaccinated with the membrane proteins and its sub-fractions. 544 
(D), Western blot: antigens recognised on the cationic proteins by pooled sera from pigs 545 
vaccinated with neutral proteins (1), and antigens recognised on the neutral proteins by pooled 546 
sera from pigs vaccinated with cationic proteins (2). 547 
 548 
Figure 3. Vaccination of pigs with GME and with the antigen Oe45 purified by gel 549 
electroelution. (A) Anti-GME IgG serum levels (mean OD ± SE) in the vaccinated pigs. 550 
Asterisks indicate the weeks when the extract was administered. Infestations with O. erraticus 551 
were carried out during weeks 5 and 6. (B) SDS-PAGE showing the purification of the 552 
Oe45antigen: band patterns of the starting GME, its fraction of membrane proteins (Memb.) and 553 
 25 
electroeluted antigen Oe45. (C) Western blot: antigens recognised on the GME by the sera from 554 
pigs vaccinated with the membrane proteins and Oe45 alone. 555 
 556 
Figure 4. (A) SDS-PAGE: band patterns of GMEs obtained from adult ticks before blood 557 
ingestion (fasted) and from fed adults taken at different times along the period of blood 558 
digestion. (B), Western blot: antigens recognized on the GMEs from fasted adults and from fed 559 
adults taken at 6, 48 and 72 hours and 15 and 24 days post-feeding by a pool of sera from the 560 
pigs vaccinated with the Oe45 antigen in trial 3. 561 
 562 
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